Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome

Psychiatry and Clinical Neurosciences

Volumn 56, Issue 3, 2002, Pages 273-274

  Kanbayashi, Takashi ^a   Ishiguro, Hideaki ^b   Aizawa, Rika ^a   Saito, Yasushi ^a   Ogawa, Yuriko ^a   Abe, Masahito ^a   Hirota, Kouichi ^b   Nishino, Seiji ^c   Shimizu, Tetsuo ^a  

^a AKITA UNIVERSITY   (Japan)

^b AKITA RED CROSS HOSPITAL   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Guillain Barr syndrome; Hypocretin; Multiple sclerosis; Narcolepsy; Orexin

Indexed keywords

HLA ANTIGEN; OREXIN A;

AUTOIMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; MULTIPLE SCLEROSIS; NARCOLEPSY; NEUROIMMUNOLOGY; PATHOPHYSIOLOGY; PROTEIN CONTENT;

ANALYSIS OF VARIANCE; CARRIER PROTEINS; FEMALE; GUILLAIN-BARRE SYNDROME; HLA ANTIGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MULTIPLE SCLEROSIS; NEUROPEPTIDES;

EID: 0036317591     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2002.00974.x     Document Type: Conference Paper

References (6)

1. Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy
2. DQ (rather than DR) gene marks susceptibility to narcolepsy
3. Guillian-Barré syndrome
4. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
5. Mononucleosis and chronic daytime sleepiness: A long-term follow-up study
6. A case of hypersomnia developed after Guillain-Barré syndrome